Correction to “Nivolumab Plus Chemotherapy or Ipilimumab Versus Chemotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma ( CheckMate 648): 29‐Month Follow‐Up From a Randomized, Open‐Label, Phase III Trial”
Fuente:
Wiley Open Access
Saved in:
| Format: | Artículo Open Access |
|---|---|
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|